Rating
Sell
Price target
Previous
Implied upside

BNP Paribas Exane analyst James Kan downgraded XPeng (NYSE: XPEV) from Neutral to Underperform.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Privacy Preference Center

Share on